Determination of debrisoquine and metabolites in human urine by gas chromatography-mass spectrometry.
A gas chromatographic-mass spectrometric analysis has been developed for the determination of debrisoquine and its metabolites in the urine of healthy individuals (controls) and patients with chronic renal failure. The sensitive and specific assay comprises selected-ion monitoring of the drug and the metabolites 4-hydroxydebrisoquine and 8-hydroxydebrisoquine using guanoxan as the internal standard. The limit of detection is ca. 0.2 microgram/ml. The clinical study shows that the healthy individuals and patients with chronic renal failure can be divided in two groups of extensive metabolizers and poor metabolizers, respectively. The extensive metabolizers excreted large amounts of 4-hydroxydebrisoquine and minor amounts of 8-hydroxydebrisoquine. The poor metabolizers excreted small amounts of 4-hydroxy metabolite, and no 8-hydroxydebrisoquine was detected in the urine.
Daumas
L
L
Laboratoire de Chimie Analytique II, Faculté de Pharmacie, Lyon, France.
Sabot
J F
JF
Vermeulen
E
E
Clapot
P
P
Allegre
F
F
Pinatel
H
H
Boucherat
M
M
Francois
B
B
D003647:Debrisoquin / Q000031:analogs & derivatives* / Q000652:urine*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007676:Kidney Failure, Chronic / Q000652:urine; D012016:Reference Values; D015203:Reproducibility of Results
C073395:8-hydroxydebrisoquin; C012359:4-hydroxydebrisoquin; D003647:Debrisoquin